Keywords: roche, buy, life, sciences, agreed, majority-owned, subsidiary

Roche to buy 454 Life Sciences

Article | 02 April 2007

Roche has agreed to buy 454 Life Sciences, a majority-owned subsidiary of CuraGen that develops and commercializes instrumentation for high-throughput DNA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing